(Q69993216)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

title

Effect of L-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

main subject

lymphoblastic leukemia

1 reference

0 references

A Bezeaud

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

L Drouet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

G Leverger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

J H Griffin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

M C Guillin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

language of work or name

English

0 references

publication date

1 May 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

7 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

issue

5 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

page(s)

698-701

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

L-asparaginase: clinical, biochemical, pharmacological, and immunological studies

7 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

Blood coagulation changes under L-asparaginase therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

L-asparaginase, antithrombin III, and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

Decrease in protein C in L-asparaginase-treated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

Deficiency of protein C in congenital thrombotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

Recurrent venous thromboembolism in patients with a partial deficiency of protein S.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

The purification of human acarboxy prothrombin. Characterization of its derivatives after thrombin cleavage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

Toxicity of L-asparaginase in children with advanced leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

L-asparaginase effect on antithrombin-III levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

Reduced antithrombin III levels during L-asparaginase therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

Antithrombin III deficiency during asparaginase therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

Fatal pulmonary embolism and antithrombin III deficiency in adult lymphoblastic leukaemia during L-asparaginase therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

L-asparaginase induced antithrombin III deficiency: evidence against the production of a hypercoagulable state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2886%2981044-7

10.1016/S0022-3476(86)81044-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2939229%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference